m+Medelevator.RU
← Поиск публикаций
Annals of the rheumatic diseases · 2018

In silico validation of the Autoinflammatory Disease Damage Index.

СтатьяПоддержка исследования: вне правительства СШАВалидационное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Ter Haar Nienke M, van Delft Amber Laetitia Justine, Annink Kim Valerie, van Stel Henk, Al-Mayouf Sulaiman M, Amaryan Gayane, Anton Jordi, Barron Karyl S, Benseler Susanne, Brogan Paul A, Cantarini Luca, Cattalini Marco, Cochino Alexis-Virgil, de Benedetti Fabrizio, Dedeoglu Fatma, de Jesus Adriana Almeida, Demirkaya Erkan, Dolezalova Pavla, Durrant Karen L, Fabio Giovanna, Gallizzi Romina, Goldbach-Mansky Raphaela, Hachulla Eric, Hentgen Veronique, Herlin Troels, Hofer Michaël, Hoffman Hal M, Insalaco Antonella, Jansson Annette F, Kallinich Tilmann, Kone-Paut Isabelle, Kozlova Anna, Kuemmerle-Deschner Jasmin Beate, Lachmann Helen J, Laxer Ronald M, Martini Alberto, Nielsen Susan, Nikishina Irina, Ombrello Amanda K, Özen Seza, Papadopoulou-Alataki Efimia, Quartier Pierre, Rigante Donato, Russo Ricardo, Simon Anna, Trachana Maria, Uziel Yosef, Ravelli Angelo, Schulert Grant, Gattorno Marco, Frenkel Joost

Аннотация

INTRODUCTION: Autoinflammatory diseases can cause irreversible tissue damage due to systemic inflammation. Recently, the Autoinflammatory Disease Damage Index (ADDI) was developed. The ADDI is the first instrument to quantify damage in familial Mediterranean fever, cryopyrin-associated periodic syndromes, mevalonate kinase deficiency and tumour necrosis factor receptor-associated periodic syndrome. The aim of this study was to validate this tool for its intended use in a clinical/research setting.

METHODS: The ADDI was scored on paper clinical cases by at least three physicians per case, independently of each other. Face and content validity were assessed by requesting comments on the ADDI. Reliability was tested by calculating the intraclass correlation coefficient (ICC) using an 'observer-nested-within-subject' design. Construct validity was determined by correlating the ADDI score to the Physician Global Assessment (PGA) of damage and disease activity. Redundancy of individual items was determined with Cronbach's alpha.

RESULTS: The ADDI was validated on a total of 110 paper clinical cases by 37 experts in autoinflammatory diseases. This yielded an ICC of 0.84 (95% CI 0.78 to 0.89). The ADDI score correlated strongly with PGA-damage (r=0.92, 95% CI 0.88 to 0.95) and was not strongly influenced by disease activity (r=0.395, 95% CI 0.21 to 0.55). After comments from disease experts, some item definitions were refined. The interitem correlation in all different categories was lower than 0.7, indicating that there was no redundancy between individual damage items.

CONCLUSION: The ADDI is a reliable and valid instrument to quantify damage in individual patients and can be used to compare disease outcomes in clinical studies.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты